We also reported preclinical data showing that T-VEC induced ICD in human melanoma cells, leading to partial maturation of DCs and uptake and cross-presentation of melanoma-derived tumor antigens to tumor-specific CD8+ T cells.17 This evidence concerns the gene CD8A and melanoma.